Publication | Open Access
Development of highly potent and specific AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer
20
Citations
34
References
2022
Year
Tumor BiologyBreast OncologyOncologyDrug-resistant Breast CancerMedicineSpecific Akr1c3 InhibitorsImmune Checkpoint InhibitorBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1